101 related articles for article (PubMed ID: 1394199)
1. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose.
DeSombre ER; Shafii B; Hanson RN; Kuivanen PC; Hughes A
Cancer Res; 1992 Oct; 52(20):5752-8. PubMed ID: 1394199
[TBL] [Abstract][Full Text] [Related]
2. Radiotoxicity of Auger electron-emitting estrogens in MCF-7 spheroids: a potential treatment for estrogen receptor-positive tumors.
Kearney T; Hughes A; Hanson RN; DeSombre ER
Radiat Res; 1999 May; 151(5):570-9. PubMed ID: 10319730
[TBL] [Abstract][Full Text] [Related]
3. Bromine-80m radiotoxicity and the potential for estrogen receptor-directed therapy with auger electrons.
DeSombre ER; Harper PV; Hughes A; Mease RC; Gatley SJ; DeJesus OT; Schwartz JL
Cancer Res; 1988 Oct; 48(20):5805-9. PubMed ID: 3167838
[TBL] [Abstract][Full Text] [Related]
4. DNA and chromosome breaks induced by iodine-123-labeled estrogen in Chinese hamster ovary cells.
Schwartz JL; Mustafi R; Hughes A; DeSombre ER
Radiat Res; 1996 Aug; 146(2):151-8. PubMed ID: 8693065
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the distribution of radioiodinated-E-17 alpha-iodovinyl-11 beta-methoxyestradiol and 2-iodo-1,1-bis(4-hydroxyphenyl)-phenylethylene estrogens in the immature female rat.
Hughes A; Gatley SJ; DeSombre ER
J Nucl Med; 1993 Feb; 34(2):272-80. PubMed ID: 8429347
[TBL] [Abstract][Full Text] [Related]
6. Cellular and subcellular studies of the radiation effects of Auger electron-emitting estrogens.
DeSombre ER; Hughes A; Landel CC; Greene G; Hanson R; Schwartz JL
Acta Oncol; 1996; 35(7):833-40. PubMed ID: 9004760
[TBL] [Abstract][Full Text] [Related]
7. [Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta].
Schomäcker K; Fischer T; Böttcher B; Mraheel SA; Scharl A; Gabruk-Szostak B; Scheidhauer K; Göhring UJ; Meller-Rehbein B; Shukla SK; Schicha H
Nuklearmedizin; 1998 Jun; 37(4):134-40. PubMed ID: 9650213
[TBL] [Abstract][Full Text] [Related]
8. Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen receptor-directed ligands with potential for therapy of estrogen receptor-positive cancers.
DeSombre ER; Mease RC; Hughes A; Harper PV; DeJesus OT; Friedman AM
Cancer Res; 1988 Feb; 48(4):899-906. PubMed ID: 3338083
[TBL] [Abstract][Full Text] [Related]
9. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
10. Therapy of estrogen receptor-positive micrometastases in the peritoneal cavity with Auger electron-emitting estrogens--theoretical and practical considerations.
DeSombre ER; Hughes A; Hanson RN; Kearney T
Acta Oncol; 2000; 39(6):659-66. PubMed ID: 11130001
[TBL] [Abstract][Full Text] [Related]
11. In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons.
Michel RB; Castillo ME; Andrews PM; Mattes MJ
Clin Cancer Res; 2004 Sep; 10(17):5957-66. PubMed ID: 15355929
[TBL] [Abstract][Full Text] [Related]
12. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
Makrigiorgos GM; Kassis AI; Baranowska-Kortylewicz J; McElvany KD; Welch MJ; Sastry KS; Adelstein SJ
Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274
[TBL] [Abstract][Full Text] [Related]
13. Characterization of high specific activity [16 alpha-123I]Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors.
Pavlik EJ; Nelson K; Gallion HH; van Nagell JR; Donaldson ES; Shih WJ; Spicer JA; Preston DF; Baranczuk RJ; Kenady DE
Cancer Res; 1990 Dec; 50(24):7799-805. PubMed ID: 2253222
[TBL] [Abstract][Full Text] [Related]
14. Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: clonogenic survival.
Walicka MA; Adelstein SJ; Kassis AI
Radiat Res; 1998 Feb; 149(2):142-6. PubMed ID: 9457893
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence.
Sarabia SF; Liehr JG
Mol Carcinog; 1999 Apr; 24(4):255-62. PubMed ID: 10326862
[TBL] [Abstract][Full Text] [Related]
16. Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16 alpha[125I]iodo-17 beta-estradiol.
Beckmann MW; Scharl A; Rosinsky BJ; Holt JA
J Cancer Res Clin Oncol; 1993; 119(4):207-14. PubMed ID: 8423195
[TBL] [Abstract][Full Text] [Related]
17. Relative biological effectiveness of accumulated 125IdU and 125I-estrogen decays in estrogen receptor-expressing MCF-7 human breast cancer cells.
Yasui L; Hughes A; DeSombre E
Radiat Res; 2001 Feb; 155(2):328-34. PubMed ID: 11175668
[TBL] [Abstract][Full Text] [Related]
18. Diethylstilbestrol (DES) labeled with Auger emitters: potential radiopharmaceutical for therapy of estrogen receptor-positive tumors and their metastases?
Fischer T; Schomacker K; Schicha H
Int J Radiat Biol; 2008 Dec; 84(12):1112-22. PubMed ID: 19061136
[TBL] [Abstract][Full Text] [Related]
19. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
20. Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells.
Kassis AI; Fayad F; Kinsey BM; Sastry KS; Adelstein SJ
Radiat Res; 1989 May; 118(2):283-94. PubMed ID: 2727257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
